74%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
74%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
74%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
74%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Afya Ltd (Class A)
Closed
SectorConsumer defensive
15 -2.47
Overview
Share price change
24h
Min
14.96
Max
15.1
Income | 102M 252M |
|---|---|
Sales | 87M 936M |
P/E Sector Avg | 10.759 26.431 |
Dividend yield | 1.58 |
Profit margin | 26.913 |
EBITDA | 173M 480M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +27.29% upside |
Dividend yield Sector Avg | 1.58% 3.28% |
|---|---|
Next Earnings | 13 lis 2025 |
Market Cap | -381M 1.3B |
|---|---|
Previous open | 17.47 |
Previous close | 15 |
News Sentiment
By Acuity
50%
50%
60 / 150 Ranking in Consumer defensive
Technical Score
By Trading Central
Confidence
Bullish Evidence
Afya Ltd (Class A) Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Afya Ltd (Class A) Forecast
Price Target
By TipRanks
27.29% upside
12 Months Forecast
Average 19.17 USD 27.29%
High 25 USD
Low 14 USD
Based on 6 Wall Street analysts offering 12 month price targets forAfya Ltd (Class A) - Dist in the last 3 months.
Sentiment
By Acuity
60 / 150 Ranking in Consumer defensive
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Afya Ltd (Class A)
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
